Analog Devices Inc. (NASDAQ: ADI) has raised its quarterly dividend by 8% to $0.99 per share, marking its 21st consecutive annual increase. The dividend is payable on March 17 to shareholders of record as of March 4.
The semiconductor giant also authorized an additional $10 billion in share repurchases, bringing its total buyback authorization to approximately $11.5 billion. Stock repurchases may be executed through open-market transactions or privately negotiated deals, with timing and volume at management’s discretion.
CEO Vincent Roche emphasized ADI’s commitment to delivering long-term shareholder value, citing the company’s ability to return 100% of free cash flow while maintaining growth investments. Over the past 21 years, ADI has distributed over $13 billion in dividends and repurchased roughly $16 billion in stock.
This move underscores ADI’s confidence in its financial stability, cash flow strength, and growth trajectory, reinforcing its position as a leader in the semiconductor industry.


FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
AFT Leaves X Over AI-Generated Images of Minors
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 



